Sahm ScreenerSaudi Stock Screenerفلتر الأسهم السعودية
Home / Nahdi Medical Co. / 2023 Annual Results

Nahdi Medical Co. 2023 Annual Results

Revenue
SAR 8.71B
Net Profit
SAR 893M
EPS
SAR 6.87
Operating Cash Flow
SAR 1.37B

Nahdi Medical Co. (4164) reported full year 2023 revenue of SAR 8.71B, up 71.0% from SAR 5.10B in 2022. Net profit came in at SAR 893M, up 0.5% year on year. Earnings per share were SAR 6.87. The company generated SAR 1.37B in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 1.53 arrived as operating cash flow — indicating Exceptional quality earnings with a cash conversion ratio of 1.53.

Key Financial Metrics

Metric20232022
RevenueSAR 8.71BSAR 5.10B
Net ProfitSAR 893MSAR 888M
Gross ProfitSAR 3.52B
Net Margin10.2%17.4%
ROE36.2%39.6%
EPSSAR 6.87
Total AssetsSAR 5.37BSAR 4.94B
Total EquitySAR 2.46BSAR 2.24B
Total LiabilitiesSAR 2.91B
Operating Cash FlowSAR 1.37B

Year on Year Comparison

Revenue increased by 71.0% compared to 2022. Net profit increased by 0.5%. Both revenue and profit grew — indicating expanding business.

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2024-03-18.